A Comparison of Sciatic Nerve Neuropathy in Diabetic and Aged Rats

Folia Biologica

Volumn 51, Issue 3-4, 2003, Pages 213-218

  Koura, Nahed H ^a  

^a NONE   (Egypt)

Author keywords

Aging; Alloxan; Diabetes; Rats; Sciatic nerve

Indexed keywords

ALLOXAN; INSULIN ZINC SUSPENSION; MYELIN;

AGED; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXOPLASM; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DIABETES MELLITUS; ELECTRON MICROSCOPY; FEMALE; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN TREATMENT; MALE; MOTOR NERVE CONDUCTION; MYELIN SHEATH; NERVE CONDUCTION; NERVE FUNCTION; NONHUMAN; RAT; SCHWANN CELL; SCIATIC NERVE; SCIATIC NEUROPATHY; SENSORY NERVE CONDUCTION;

AGE OF ONSET; AGING; ANIMALS; DIABETES COMPLICATIONS; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; HYPERGLYCEMIA; NEURAL CONDUCTION; RATS; SCIATIC NERVE; SCIATIC NEUROPATHY;

ANIMALIA;

EID: 1042291314     PISSN: 00155497     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. BIESSELS G. J., CRISTINO N. A., RUTTEN G. J., HAMERS F. P., ERKELENS D. W., GISPEN W. H. 1999. Neurophysiological changes in the central and peripheral nervous system of streptozotocin-diabetic rats. Course of development and effects of insulin treatment. Brain 122: 757-768.
2. BISCHOFF A. 1973. Ultrastructural pathology of peripheral nervous system in early diabetes. Vascular and pathological changes in early diabetes. Advances in metabolic disorders, suppl. 2, Camerni-Davalos R. A., Cole H. S. eds. New York - London, Academic Press): 411-449.
3. BOWE C. M., KOCSIS J. D., TARG E. F., WAXMAN S. G. 1987. Physiological effects of 4- aminopyridine on demyelinated motor and sensory fibers. Ann. Neurol. 22: 264-268.
4. CAMERON N. E., COTTER M. A., ROBERTSON S. 1989. The effect of aldose reductase inhibition on the pattern of nerve conduction deficits in diabetic rats. Q. J. exp. Physiol. 74: 917-926.
5. CHOPRA J. S., FONNIN T. 1971. Pathology of diabetic neuropathy. J. Path. 104: 175-184.
6. COTTER M. A., CAMERON N. E. 1997. Effects of dietary supplementation with arachidonic acid rich in oils in nerve conduction and blood flow in streptozotocin-diabetic rats. Prostaglandins Leukot. Essent Fatty Acids 56: 337-343.
7. DE KONING P., GISPEN W. H. 1987. Org. 2766 improves functional and electrophysiological aspects of regenerating sciatic nerve in the rat. Peptides 8: 415-422.
8. DOCKERY P., SHARMA A. K. 1990. Ultrastructural abnormalities of myelinated fibres in the tibial nerve of streptozotocin-diabetic rats. J. Neurol. Sci. 98: 327-345.
9. DYCK P. J., KARNES J. L., DAUBE J., O'BRIEN P., SERVICE F. J. 1985. Clinical and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy. Brain 108: 861-880.
10. DYCK P. J. 1989. Hypoxic neuropathy: Does hypoxia play a role in diabetic neuropathy? The 1988 Robert Wartenberg lecture. Neurology 39: 111-118.
11. ELIASSON S. G. 1964.. Nerve conduction changes in experimental diabetes. J. Clin. Invest. 43: 2353-2358.
12. FAHIM M. A., ROBBINS N. 1982. Ultrastructural studies of young and old mouse neuromuscular junctions. J. Neurocytol. 11: 641-656.
13. FRAHER J. P., O'SULLIVAN V. R. 1989. Age changes in axon number along the cervical ventral spinal nerve roots in rats. J. Comp. Neurol. 280: 171-182.
14. FRIEDE R. L., SAMORAJSKI T. 1970. Axon caliber related to neurofilaments and microtubules in sciatic nerve fibers of rats and mice. Anat. Rec. 167: 379-388.
15. GREENE D. A., DE JESUS P. V., WINEGRAD A. I. 1975. Effects of insulin and dietary myoinositol on impaired peripheral nerve conduction velocity in acute streptozotocin diabetes. J. Clin. Invest. 55: 1326-1336.
16. GREGERSEN G. 1967. Diabetic neuropathy: influence of age, sex, metabolic control and duration of diabetes on motor conduction velocity. Neurology 17: 972-980.
17. HILDEBRAND C. 1972. Evidence for a correlation between myelin period and number of myelin lamellae in fibres of the feline spinal cord white matter. J. Neurocytol. 1: 223-232.
18. HOLTZMAN E., NOVIKOFF A. B. 1965. Lysosomes in the rat sciatic nerve following crush. J. Cell Biol. 27: 651-669.
19. JAKOBSEN J. 1976. Axonal dwinding in experimental diabetes: A study of cross sectioned nerves. Diabetologia 12: 539-546.
20. DE JONG G. I., JANSEN A. S., HORVATH E., GISPEN W. H., LUITEN P. G. 1992. Nimodipine effects on cerebral microvessels and sciatic nerve in aging rats. Neurobiol. Aging 13: 73-81.
21. PEREYRA P. M., ZHANG W., SCHMIDT M., BECKER L. E. 1992. Development of myelinated and unmyelinated fibers of human vagus nerve during the first year of life. J. Neurol. Sci. 110: 107-113.
22. RESKE-NIELSEN E., GREGERSEN G., HARMSEN A., LUNDBAEK K. 1970. Morphlogical abnormalities of the terminal apparatus in recent juvenile diabetes. Diabetologia 6: 104-109.
23. SPIRO M. J. 1984. Effect of diabetes on the sugar nucleotides in several tissues of the rat. Diabetologia 26: 70-75.
24. YAGIHASHI S., KAMIJO M., WATANABE K. 1990.. Reduced myelinated fiber size correlates with loss of axonal neurofilaments in peripheral nerve chronically streptozotocin diabetic rats. Amer. J. Pathol. 136: 1365-1373.
25. YAGIHASHI S. 1995. Pathology and pathogenesis mechanisms of diabetic neuropathy. Diabetes Metab. Rev. 11: 193-225.
26. YASUDA H., TERADA M., TANIGUCHI Y., SASAKI T., MAEDA K., HANEDA M., KASHIWAGI A., KIKKAWA R. 1999. Impaired regeneration and no amelioration with aldose reductase inhibitor in crushed unmyelinated nerve fibers of diabetic rats. Neuroreport 10: 2405-2409.
27. YOUNG R. J., MACINTYRE C. C., MARTYN C. N., PRESCOTT R. J., EWING D. J., SMITH A. F., VEBERTI G., CLARKE B. F. 1986. Progression of subclinical polyneuropathy in young patients with type 1 (insulin dependent) diabetes: associations with glyeaemic control and microangiopathy (microvascular complications). Diabetologia 29: 156-161.